bioAffinity Technologies, Inc. (BIAFW) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$9.33M | -28.4% |
| 2024 | -$7.26M | -20.3% |
| 2023 | -$6.04M | -48.3% |
| 2022 | -$4.07M | -98.7% |
| 2021 | -$2.05M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$9.33M | -28.4% |
| 2024 | -$7.26M | -20.3% |
| 2023 | -$6.04M | -48.3% |
| 2022 | -$4.07M | -98.7% |
| 2021 | -$2.05M | — |